Aurobindo Pharma Limited: corporate announcements

16 records, the earliest from 11 Sep 2026. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.

16 shown.

Sign in to see more, or upgrade your plan to see the full history. Sign in

DateCategorySubject
3 Oct 2026Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
2 Oct 2026Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition
2 Oct 2026Company Update Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
1 Oct 2026Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition
30 Sep 2026Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
29 Sep 2026Company Update Aurobindo Pharma Ltd - 524804 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
21 Sep 2026Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Sep 2026Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
15 Sep 2026Company Update Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Inspection At Unit-II Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company
12 Sep 2026Company Update Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.